Related Experiment Video
Updated: Feb 27, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasia
Roberto Bellelli1, Donata Vitagliano2, Giorgia Federico1
1Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universita' Federico II c/o Istituto di Endocrinologia e Oncologia Sperimentale, CNR, Via S Pansini 5, 80131 Naples, Italy.
Abstract:
Here we describe a conditional doxycycline-dependent mouse model of RET/PTC3 (NCOA4-RET) oncogene-induced thyroid tumorigenesis. In these mice, after 10 days of doxycycline (dox) administration, RET/PTC3 expression induced mitogen activated protein kinase (MAPK) stimulation and a proliferative response which resulted in the formation of hyperplastic thyroid lesions. This was followed, after 2 months, by growth arrest accompanied by typical features of oncogene-induced senescence (OIS), including upregulation of p16INK4A and p21CIP, positivity at the Sudan black B, activation of the DNA damage response (DDR) markers γH2AX and pChk2 T68, and induction of p53 and p19ARF. After 5 months, about half of thyroid lesions escaped OIS and formed tumors that remained dependent on RET/PTC3 expression. This progression was accompanied by activation of AKT-FOXO1/3a pathway and increased serum TSH levels.
Insights
A new mouse model reveals how RET/PTC3 oncogene drives thyroid tumors. Initially causing hyperplasia, the oncogene triggers senescence, but some lesions eventually escape to form tumors dependent on RET/PTC3 expression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Thyroid tumors are a significant health concern.
- The role of RET/PTC rearrangements in thyroid tumorigenesis is well-established.
- Understanding the precise mechanisms of oncogene-induced thyroid tumor development is crucial for therapeutic strategies.
Purpose of the Study:
- To develop and characterize a conditional doxycycline-dependent mouse model for studying RET/PTC3 (NCOA4-RET) oncogene-induced thyroid tumorigenesis.
- To investigate the temporal progression of thyroid lesions from hyperplasia to senescence and eventual tumor formation.
- To elucidate the molecular pathways involved in oncogene-induced thyroid cancer.
Main Methods:
- Generation of a conditional doxycycline-dependent mouse model expressing RET/PTC3.
- Administration of doxycycline to induce oncogene expression.
- Histopathological analysis of thyroid lesions at various time points (10 days, 2 months, 5 months).
- Molecular analysis including Western blotting and assessment of senescence markers (p16INK4A, p21CIP), DNA damage response (DDR) markers (γH2AX, pChk2 T68), and signaling pathways (MAPK, AKT-FOXO1/3a).
- Measurement of serum Thyroid-Stimulating Hormone (TSH) levels.
Main Results:
- Doxycycline administration rapidly induced RET/PTC3 expression, leading to MAPK stimulation and thyroid hyperplasia within 10 days.
- After 2 months, lesions exhibited oncogene-induced senescence (OIS) characterized by p16INK4A, p21CIP, Sudan black B positivity, DDR activation (γH2AX, pChk2 T68), and induction of p53 and p19ARF.
- Approximately 50% of thyroid lesions escaped OIS after 5 months, forming tumors dependent on RET/PTC3 expression, associated with AKT-FOXO1/3a pathway activation and elevated serum TSH levels.
Conclusions:
- The RET/PTC3 oncogene can induce thyroid hyperplasia, followed by a period of oncogene-induced senescence.
- Tumorigenesis can occur through the escape of thyroid lesions from senescence, maintaining dependence on the oncogene.
- This model provides a valuable tool for studying thyroid cancer progression and identifying potential therapeutic targets, highlighting the role of the AKT-FOXO1/3a pathway and TSH in tumor maintenance.
Related Concept Videos
Replicative Cell Senescence
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

